Association between interleukin-10 polymorphisms and sepsis: A meta-analysis

Epidemiology and Infection

Volumn 143, Issue 2, 2015, Pages 366-375

  Pan, W ^a   Zhang, A Q ^a   Yue, C L ^a   Gao, J W ^a   Zeng, L ^a   Gu, W ^a   Jiang, J X ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Genetic polymorphism; interleukin 10; sepsis

Indexed keywords

INTERLEUKIN 10; IL10 PROTEIN, HUMAN;

ARTICLE; ASIAN; CAUCASIAN; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SENSITIVITY ANALYSIS; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; TRANSCRIPTION REGULATION; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-10; POLYMORPHISM, GENETIC; SEPSIS;

EID: 84925228864     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814000703     Document Type: Article

References (40)

1. Bone RC, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
2. Martin GS, et al. The epidemiology of sepsis in the United States from 1979 through 2000. New England Journal of Medicine 2003; 348: 1546-1554.
3. Bochud PY, et al. Innate immunogenetics: a tool for exploring new frontiers of host defence. Lancet Infectious Diseases 2007; 7: 531-542.
4. Mosmann TR. Properties and functions of interleukin-10. Advances in Immunology 1994; 56: 1-26.
5. Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunological Reviews 2008; 226: 205-218.
6. Neidhardt R, et al. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. Journal of Trauma 1997; 42: 863-870.
7. Maier B, et al. Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock 2007; 28: 668-674.
8. McDaniel DO, et al. Molecular analysis of inflammatory markers in trauma patients at risk of postinjury complications. Journal of Trauma 2007; 63: 147-157.
9. Westendorp RG, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349: 170-173.
10. Stewart D, et al. Genetic contribution to the septic response in a mouse model. Shock 2002; 18: 342-347.
11. Turner DM, et al. An investigation of polymorphism in the interleukin-10 gene promoter. European Journal of Immunogenetics 1997; 24: 1-8.
12. Baier RJ, Loggins J, Yanamandra K. IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants. BMC Medicine 2006; 4: 10.
13. Schaaf BM, et al. Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. American Journal of Respiratory and Critical Care Medicine 2003; 168: 476-480.
14. Jin X, et al. Association of interleukin-10-1082 G/G genotype with lower mortality of acute respiratory distress syndrome in a Chinese population. Genetic Testing and Molecular Biomarkers 2011; 15: 203-206.
15. Ouyang L, et al. Quantitative analysis of the association between interleukin-10 1082A/G polymorphism and susceptibility to sepsis. Molecular Biology Reports 2013; 40: 4327-4332.
16. Gu W, et al. Clinical relevance of 13 cytokine gene polymorphisms in Chinese major trauma patients. Intensive Care Medicine 2010; 36: 1261-1265.
17. Zeng L, et al. Clinical relevance of the interleukin 10 promoter polymorphisms in Chinese Han patients with major trauma: genetic association studies. Critical Care 2009; 13: R188.
18. Wells OCB, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, 2006 (www.ohri.ca/programs/clinical- epidemiology/oxford.htm).
19. Higgins JP, et al. Measuring inconsistency in metaanalyses. British Medical Journal 2003; 327: 557-560.
20. Egger M, et al. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997; 315: 629-634.
21. Shimada T, et al. Outcome prediction in sepsis combined use of genetic polymorphisms - a study in Japanese population. Cytokine 2011; 54: 79-84.
22. Davis SM, et al. The association of innate immune response gene polymorphisms and puerperal group A streptococcal sepsis. American Journal of Obstetrics and Gynecology 2010; 202: e301-308.
23. Huebinger RM, et al. IL-10 polymorphism associated with decreased risk for mortality after burn injury. Journal of Surgical Research 2010; 164: E141-E145.
24. Nakada TA, et al. Influence of toll-like receptor 4, CD14, tumor necrosis factor, and interleukine-10 gene polymorphisms on clinical outcome in Japanese critically ill patients. Journal of Surgical Research 2005; 129: 322-328.
25. Balding J, et al. Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease? Genes and Immunity 2003; 4: 533-540.
26. Lowe PR, et al. Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Critical Care Medicine 2003; 31: 34-38.
27. Shu Q, et al. IL-10 polymorphism is associated with increased incidence of severe sepsis. Chinese Medical Journal 2003; 116: 1756-1759.
28. Palumbo AA, et al. Analysis of IL-6, IL-10 and IL-17 genetic polymorphisms as risk factors for sepsis development in burned patients. Burns 2012; 38: 208-213.
29. Carregaro F, et al. Polymorphisms IL10-819 and TLR-2 are potentially associated with sepsis in Brazilian patients. Memorias do Instituto Oswaldo Cruz 2010; 105: 649-656.
30. Emonts M, et al. Polymorphisms in PARP, IL1B, IL4, IL10, C1INH, DEFB1, and DEFA4 in meningococcal disease in three populations. Shock 2010; 34: 17-22.
31. Abdel H, et al. Genetic polymorphisms of IL-6-174 and IL-10-1082 in full term neonates with late onset blood stream infections. Journal of Pediatric Infectious Diseases 2009; 4: 357-365.
32. McDaniel DO, et al. Molecular analysis of inflammatory markers in trauma patients at risk of postinjury complications. Journal of Trauma - Injury, Infection and Critical Care 2007; 63: 147-157.
33. Garnacho-Montero J, et al. Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis. Critical Care 2006; 10: R111.
34. Stanilova SA, et al. Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility. Intensive Care Medicine 2006; 32: 260-266.
35. Zhang DL, et al. Association of polymorphisms of IL and CD14 genes with acute severe pancreatitis and septic shock. World Journal of Gastroenterology 2005; 11: 4409-4413.
36. Jaber BL, et al. Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine 2004; 25: 212-219.
37. Treszl A, et al. Genetic variants of TNF-(alpha), IL-1 (beta), IL-4 receptor (alpha)-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants. Biology of the Neonate 2003; 83: 241-245.
38. Munafo MR, et al. Meta-analysis of genetic association studies. Trends in Genetics 2004; 20: 439-444.
39. Zintzaras E. Impact of Hardy-Weinberg equilibrium deviation on allele-based risk effect of genetic association studies and meta-analysis. European Journal of Epidemiology 2010; 25: 553-560.
40. Thakkinstian A, et al. A method for meta-analysis of molecular association studies. Statistics in Medicine 2005; 24: 1291-1306.